- Home
- FPI vs ATAI Comparison
FPI vs ATAI Comparison
Compare FPI & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPI
- ATAI
- Stock Information
- Founded
- FPI 2013
- ATAI 2018
- Country
- FPI United States
- ATAI Germany
- Employees
- FPI N/A
- ATAI N/A
- Industry
- FPI Real Estate Investment Trusts
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- FPI Real Estate
- ATAI Health Care
- Exchange
- FPI Nasdaq
- ATAI Nasdaq
- Market Cap
- FPI 516.0M
- ATAI 444.7M
- IPO Year
- FPI 2014
- ATAI 2021
- Fundamental
- Price
- FPI $11.08
- ATAI $2.61
- Analyst Decision
- FPI
- ATAI Strong Buy
- Analyst Count
- FPI 0
- ATAI 2
- Target Price
- FPI N/A
- ATAI $11.00
- AVG Volume (30 Days)
- FPI 466.0K
- ATAI 5.9M
- Earning Date
- FPI 07-23-2025
- ATAI 08-12-2025
- Dividend Yield
- FPI 2.17%
- ATAI N/A
- EPS Growth
- FPI 104.48
- ATAI N/A
- EPS
- FPI 1.09
- ATAI N/A
- Revenue
- FPI $56,535,000.00
- ATAI $1,863,000.00
- Revenue This Year
- FPI N/A
- ATAI $554.22
- Revenue Next Year
- FPI N/A
- ATAI N/A
- P/E Ratio
- FPI $10.19
- ATAI N/A
- Revenue Growth
- FPI N/A
- ATAI 572.56
- 52 Week Low
- FPI $9.66
- ATAI $1.03
- 52 Week High
- FPI $12.87
- ATAI $2.99
- Technical
- Relative Strength Index (RSI)
- FPI 42.06
- ATAI 58.55
- Support Level
- FPI $11.43
- ATAI $2.62
- Resistance Level
- FPI $11.69
- ATAI $2.99
- Average True Range (ATR)
- FPI 0.17
- ATAI 0.23
- MACD
- FPI -0.07
- ATAI 0.02
- Stochastic Oscillator
- FPI 15.38
- ATAI 58.89
About FPI Farmland Partners Inc.
Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.